PGA Tour bound Tom McKibbin has his sights set on claiming his second DP World Tour title this week as he wraps up 2024 at ...

The most recent trading session ended with Amgen (AMGN) standing at $273.41, reflecting a -0.85% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which registered a ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Naveen Gullapalli has been appointed as Managing Director of Amgen's India Technology and Innovation Hub in Hyderabad, ...

These bullet-by-bullet explanations have been constructed using the accompanying table.

Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...

Amgen appointed Naveen Gullapalli, former Novartis executive, as Managing Director of Amgen India. Gullapalli will lead Amgen ...

The K Club hosted The Ryder Cup in 2006, when Ian Woosnam’s European side retained their title by a record-equalling 18½ - 9½ ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Past champion Shane Lowry has been confirmed for 2025 Amgen Irish Open from September 4-7, 2025. Lowry will tee it up at The ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The company’s ...

Gullapalli will oversee the Amgen India Technology and Innovation hub, leveraging his extensive expertise in global ...